Page last updated: 2024-08-24

irinotecan and icrf 193

irinotecan has been researched along with icrf 193 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furue, H	1
Ishida, R; Nishida, K; Seto, M	1

Reviews

1 review(s) available for irinotecan and icrf 193

Article	Year
[Topoisomerase inhibitors developing in Japan]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzopyrans; Camptothecin; Diketopiperazines; Glycosides; Humans; Irinotecan; Neoplasms; Phenazines; Piperazines; Razoxane; Topotecan	1993

Other Studies

1 other study(ies) available for irinotecan and icrf 193

Article	Year
Different susceptibilities of postmitotic checkpoint-proficient and -deficient Balb / 3T3 cells to ICRF-193, a catalytic inhibitor of DNA topoisomerase II. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:2 Topics: 3T3 Cells; Animals; Camptothecin; Cell Survival; Chromosome Segregation; Diketopiperazines; DNA; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Irinotecan; Mice; Mitosis; Piperazines; S Phase; Topoisomerase II Inhibitors	2001

Article

Year

Different susceptibilities of postmitotic checkpoint-proficient and -deficient Balb / 3T3 cells to ICRF-193, a catalytic inhibitor of DNA topoisomerase II.

Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:2

Topics: 3T3 Cells; Animals; Camptothecin; Cell Survival; Chromosome Segregation; Diketopiperazines; DNA; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Irinotecan; Mice; Mitosis; Piperazines; S Phase; Topoisomerase II Inhibitors

2001